CD8A and neoplasm: In contrast, 65-weeks-old tumour bearing Mdr2−/− mice showed significantly increased numbers of CD8+ T cells in response to early HO-1 induction compared to PBS treated animals, which likely contributes to a more efficient anti-tumour immune response.